Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 231,008 | 261,338 | 234,738 | 264,560 | 194,701 |
| Receivables | 31,045 | 29,117 | 22,918 | 26,184 | 31,762 |
| Inventories | 4,776 | 4,184 | 18,042 | 17,763 | 17,447 |
| Other current assets | 4,265 | 6,084 | 5,523 | 5,664 | 7,180 |
| TOTAL | $276,768 | $306,335 | $287,149 | $318,755 | $257,989 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 5,156 |
| Other Non-Current Assets | 14,728 | 16,815 | 2,609 | 2,805 | 9,394 |
| TOTAL | $14,728 | $16,815 | $2,609 | $2,806 | $14,550 |
| Total Assets | $291,496 | $323,150 | $289,758 | $321,561 | $272,539 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,635 | 3,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,295 | 9,175 | 8,119 | 9,616 | 15,592 |
| Accrued Expenses | 57,698 | 57,988 | 53,925 | 54,984 | 42,202 |
| TOTAL | $67,628 | $70,163 | $62,044 | $64,600 | $57,794 |
| Non-Current Liabilities | |||||
| Long Term Debt | 111,042 | 112,452 | 115,206 | 114,473 | 113,823 |
| Other Non-Current Liabilities | 329,203 | 326,369 | 350,691 | 341,672 | 339,145 |
| TOTAL | $440,245 | $438,821 | $465,897 | $456,145 | $452,968 |
| Total Liabilities | $507,873 | $508,984 | $527,941 | $520,745 | $510,762 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,191 | 127,044 | 123,877 | 112,499 | 99,178 |
| Common Shares | 11,227 | 11,080 | 9,763 | 9,753 | 8,439 |
| Retained earnings | -1,668,909 | -1,635,941 | -1,629,532 | -1,588,566 | -1,531,920 |
| Other shareholders' equity | -1,007 | -722 | -907 | -595 | -1,299 |
| TOTAL | $-216,377 | $-185,834 | $-238,183 | $-199,184 | $-238,223 |
| Total Liabilities And Equity | $291,496 | $323,150 | $289,758 | $321,561 | $272,539 |